VIMTALABSNSEVimta Labs Limited· PharmaceuticalsLowNeutral
Announced Fri, 27 Mar · 20:09 IST

Vimta Labs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹402.00
prior close
₹394.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3+0.7+0.9+0.5+2.1+2.1+3.2+4.7+10.8+15.3+17.4+13.7+13.9+45.7
Up moveDown movePending
AI summary

Vimta Labs Limited has informed the exchanges that the analyst/institutional investor meet originally scheduled for 27 March 2026 has been rescheduled. The meeting with Valcore Capital will now take place on Tuesday, 31 March 2026, from 3:00 PM to 4:00 PM IST via an online one-on-one session. Additionally, the company has scheduled a new one-on-one online meeting with CVC Partners on the same day from 4:00 PM to 5:00 PM IST. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during these meetings. The disclosure was filed under SEBI LODR Regulation 30 at shorter notice due to the mutual availability of management and participants.

Likely market impact

This is a routine regulatory disclosure and is unlikely to have any direct impact on the stock price. The continued engagement with institutional investors and PE firms like CVC Partners and Valcore Capital indicates ongoing institutional interest in the company.